Department of Health and Human Services October 9, 2014 – Federal Register Recent Federal Regulation Documents

Extension of Deadline; Preschool Development Grants-Development Grants and Preschool Development Grants-Expansion Grants
Document Number: 2014-24265
Type: Notice
Date: 2014-10-09
Agency: Department of Education, Department of Health and Human Services
On August 18, 2014, the Departments of Education and Health and Human Services (Departments) published in the Federal Register (79 FR 48853, 79 FR 48873) notices inviting applications for new awards for fiscal year 2014 for the Preschool Development GrantsDevelopment Grants and Preschool Development GrantsExpansion Grants programs. The notices established October 14, 2014, as the deadline date for eligible applicants to apply for funding under the programs. However, the Departments have been informed that the Grants.gov Web site will be unavailable to applicants on October 11-12, 2014, due to a scheduled maintenance outage. To allow applicants additional time to complete their applications as a result of this outage, we are extending the deadline date for transmittal of applications to October 15, 2014.
Policy on Conferring With Urban Indian Organizations; Correction
Document Number: 2014-24154
Type: Notice
Date: 2014-10-09
Agency: Department of Health and Human Services, Indian Health Service
The Indian Health Service is issuing this Notice to correct the effective date from October 29, 2014 to September 22, 2014 for the final Policy for Conferring with Urban Indian Organizations. The notice published at 79 FR 58359, September 29, 2014.
International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH GL30); Guidance for Industry on Pharmacovigilance of Veterinary Medicinal Products: Controlled List of Terms; Availability
Document Number: 2014-24152
Type: Notice
Date: 2014-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry (GFI #143) entitled ``Guidance for Industry on Pharmacovigilance of Veterinary Medicinal Products: Controlled List of Terms'' (VICH GL30). This guidance has been developed for veterinary use by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). The purpose of this VICH guidance document is to describe the controlled lists of terms critical to completing the controlled data fields as identified in the guidance entitled ``Data Elements for Submission of Veterinary Adverse Event Reports to the Center for Veterinary Medicine'' (GFI #188), available on the FDA Web site at: http://www.fda.gov/AnimalVeterinary/ GuidanceComplianceEnforcement/GuidanceforIndustry/ucm042450.h tm.
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2014-24111
Type: Notice
Date: 2014-10-09
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee
Document Number: 2014-24074
Type: Notice
Date: 2014-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the Tobacco Products Scientific Advisory Committee, Office of Science, Center for Tobacco Products. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore, encourages nominations of appropriately qualified candidates from these groups.
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
Document Number: 2014-24064
Type: Notice
Date: 2014-10-09
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings
Document Number: 2014-24063
Type: Notice
Date: 2014-10-09
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting
Document Number: 2014-24061
Type: Notice
Date: 2014-10-09
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Environmental Health Sciences; Notice of Closed Meeting
Document Number: 2014-24060
Type: Notice
Date: 2014-10-09
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review Notice of Closed Meetings
Document Number: 2014-24059
Type: Notice
Date: 2014-10-09
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
Document Number: 2014-24058
Type: Notice
Date: 2014-10-09
Agency: Department of Health and Human Services, National Institutes of Health
Science Advisory Board to the National Center for Toxicological Research Advisory Committee; Notice of Meeting
Document Number: 2014-24039
Type: Notice
Date: 2014-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
Oncologic Drugs Advisory Committee; Notice of Meeting
Document Number: 2014-24038
Type: Notice
Date: 2014-10-09
Agency: Food and Drug Administration, Department of Health and Human Services
Medicare and Medicaid Program: Conditions of Participation for Home Health Agencies
Document Number: 2014-23895
Type: Proposed Rule
Date: 2014-10-09
Agency: Department of Health and Human Services, Centers for Medicare and Medicaid Services
This proposed rule would revise the current conditions of participation (CoPs) that home health agencies (HHAs) must meet in order to participate in the Medicare and Medicaid programs. The proposed requirements would focus on the care delivered to patients by home health agencies, reflect an interdisciplinary view of patient care, allow home health agencies greater flexibility in meeting quality care standards, and eliminate unnecessary procedural requirements. These changes are an integral part of our overall effort to achieve broad-based, measurable improvements in the quality of care furnished through the Medicare and Medicaid programs, while at the same time eliminating unnecessary procedural burdens on providers.